A 20 mg Hemi Pharma tirzepatide product manufactured for research interest in how GIP and GLP-1 receptor activity can be examined together.
| Feature | Details |
| Brand | Hemi Pharma |
| Product | Tirzepatide 20mg |
| Active Material | Tirzepatide |
| Total Amount | 20 mg |
| Molecular Type | Synthetic peptide |
| Research Focus | GIP and GLP-1 receptor activity |
| Category | Research material |
| Application | Only for researches, experiments, and studies |
£120.00
Smart Packaging
Secure Payment
14-Day Returns
Tirzepatide is a 39-amino-acid peptide designed to interact with both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its dual-receptor activity makes it relevant to research examining how these signalling systems work together and influence related metabolic processes.
The Hemi Pharma 20mg provides a sufficient quantity of tirzepatide for laboratory research. The details related to batch, quality information, and supporting documentation found in the documents provided with your order from Hemi Pharma.
£41.00
£120.00
£34.00
